.svg){kind=small}
Apr-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of Maryland, Momenta's presence in the concentrates category began with a rank of 28 in January 2026. However, the subsequent months saw the brand drop out of the top 30, indicating a potential challenge in maintaining its market position in this category. This decline could suggest a need for strategic adjustments to regain traction among competitors. Despite the initial entry into the top ranks, the absence from the list in the following months highlights the volatility and competitive nature of the cannabis market in Maryland.
While specific sales figures beyond January are not disclosed, the initial sales value suggests a promising start for Momenta in Maryland's concentrates market. However, the lack of sustained ranking in the top 30 through April may point to either increased competition or shifts in consumer preferences. Understanding these dynamics can be crucial for stakeholders looking to capitalize on market opportunities or address potential weaknesses. This scenario underscores the importance of continuous market analysis and adaptive strategies to maintain relevance in a rapidly evolving industry.
Competitive Landscape
In the Maryland concentrates market, Momenta has faced significant competition, impacting its rank and sales trajectory. Starting in January 2026, Momenta was ranked 28th, but it did not maintain a presence in the top 20 in subsequent months, indicating a struggle to gain a stronger foothold. Competitors like Roll One / R.O. have consistently outperformed Momenta, holding a solid 16th position in January with significantly higher sales figures. Meanwhile, Avexia and BLVCK MRKT / BL^CK MRKT have shown fluctuations, with Avexia reappearing in March at 27th and BLVCK MRKT entering the ranks in February at 28th. These dynamics suggest that while Momenta has maintained a presence, it needs strategic adjustments to enhance its competitive edge and climb the ranks in a market dominated by more established brands.
Notable Products
In April 2026, the top-performing product for Momenta was the Ripped Off Runtz RSO Syringe (1g) in the Concentrates category, regaining its top rank from February, with impressive sales of 94 units. The Kush Lato RSO Syringe (1g) dropped to second place, despite a strong performance in February when it was unranked. W99 RSO Syringe (1g) maintained a steady presence, climbing from fourth to third place. The White 99 RSO Syringe (1g) slipped from third to fourth, showing a decline in sales over the months. Notably, MAC V2 RSO Syringe (1g) was absent from the rankings in April, following a peak in January.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
